Last Updated: November 14, 2022    


Research Featured

California man appears to be another person cured of HIV after a stem cell transplant 

Aidsmap | August 2, 2022

Lenacapavir for HIV-1 — Potential Promise of a Long-Acting Antiretroviral Drug

NEJM | May 12, 2022

Using Science To Solve Oral Health Inequities

National Institute of Dental and Craniofacial Research | June 14, 2022

Combination anti-HIV antibody infusions suppress virus for prolonged period

NIH | June 1, 2022

Top 5 HIV cure and vaccine stories from CROI 2022

Aidsmap | March 2, 2022

Oral Fungal Infections: Past, Present, and Future 

Front Oral Health. 2022 Feb 3;3:838639. doi: 10.3389/froh.2022.838639. eCollection 2022.

Moderna Launches Clinical Trials for HIV Vaccine

WebMD | January 28, 2022

“Kick and Kill” Strategy Eliminates HIV Cells in 40% of Mice

Contagion Live | January 12, 2022

Latency reversal plus natural killer cells diminish HIV reservoir in vivo

Nature Communications | January 10, 2022

Jennifer Webster-Cyriaque Joins NIDCR as Deputy Director

NIH | November 18, 2021

NIAID Researchers Identify How Two People Controlled HIV After Stopping Treatment

NIH | October 29, 2021

Controlling HIV

Harvard Medical School | September 10, 2021

Moderna set to start human trials of experimental mRNA HIV vaccine - Clinical Trials Arena 

Clinical Trials Arena | August 18, 2021

NIH Makes Substantial New Investment of Over $265M in HIV Cure Research

POZ | August 17, 2021

First Human Trial of HIV Vaccine Produced Immune Response in 97% of Volunteers 

Good News Network | April 17, 2021

Excision BioTherapeutics Has Secured $60M to Proceed with HIV Clinical Trial 

Philadelphia magazine | March 5, 2021

Antibody Infusions Prevent Acquisition of Some HIV Strains, NIH Studies Find | January 26, 2021

News Updates

Researchers provide new insights into the vexing process that makes HIV stealthy 

News Medical | November 14, 2022

Do broadly neutralising antibodies really have a future in treating HIV?

Aidsmap | November 11, 2022

A Step Toward Eliminating Reservoir Cells?

amfAR, The Foundation for AIDS Research | November 9, 2022

Researchers at Duke School of Medicine receive $25.9 million grant for HIV vaccine research

Duke Chronicle | November 7, 2022

IDWeek 2022 — Meeting Report

NEJM Journal Watch | November 4, 2022

Potential Cure for HIV from CRISPR Gene Editing in Phase 1/2 Clinical Trial 

Contagion Live | October 16, 2022

Gut Microbes Could Play Role in HIV Infection | October 4, 2022

Study reveals new strategy to create an effective HIV vaccine

Mint | October 4, 2022

HIV Vaccine Shows Promise After Decades of Research

AARP | October 4, 2022

Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms

Nature | October 1, 2022

Gut microbiome could contribute to a person's risk for HIV infection, research suggests 

News Medical | September 30, 2022

Merck to Initiate New Phase 3 Clinical Program with Lower Dose of Daily Oral Islatravir in Combination with Doravirine for Treatment of People with HIV-1 Infection

Merck | September 20, 2022 6:45 am ET

License to Kill: Latency HIV-CRISPR pinpoints how to blow latent HIV's cover

Fred Hutch | September 19, 2022

Duke researchers find possible HIV vaccine component

WRAL TechWire | September 17, 2022

Excision's CRISPR gene editing therapy for HIV is heading into human testing after FDA clearance 

Fierce Biotech | September 17, 2022

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies

Nature | August 12, 2022

Moderna, Excision each enter HIV battle with mRNA and CRISPR tech

Fierce Biotech

Single-cell studies offer new view of how HIV infections persist—and might be cured 

Science | August 3, 2022

Novel HIV combination therapies could prevent viral escape and rebound

University of Washington | July 22, 2022

Combinations of broadly neutralizing antibodies may be a more effective approach to treat HIV 

News-Medical | July 20, 2022

Medical breakthrough! Drug developed by gene editing could cure HIV-AIDS

DNA India | July 13, 2022

HIV breakthrough: Single injection treatment 'defeats virus' during study in world first 

Daily Express | July 3, 2022

Promising Stem Cell Therapy in the Management of HIV & AIDS: A Narrative Review

Dove Medical Press | July 2, 2022

How Far Away Is a Cure for HIV?

TheBody | June 30, 2022

Ascletis Embarks on Mid-stage Study of Potentially Functional Cure for HIV

BioSpace | June 28, 2022

UB program secures $12.8 million to improve the quality of global HIV research 

News-Medical | June 16, 2022

Are we on our way to a one-time treatment for HIV?

Drug Target Review | June 15, 2022

HIV can be treated: Vaccine developed by gene editing could cure AIDS

India Today | June 15, 2022

What's in a name: using person-centred language in HIV research

Aidsmap | June 13, 2022

HIV drug may be a potential treatment for dementia: Study

IndiaTV News | May 31, 2022

Trial to Evaluate Anti-Cytomegalovirus Drug in Treating Inflammation in Patients With HIV 

Pharmacy Times | April 25, 2022

Miller School, CUNY Collaborate on $3.9 Million Study on HIV Risk and Meth Use in Gay Men 

InventUM | University of Miami Miller School of Medicine | April 25, 2022

Methamphetamine Enhances Cryptococcus neoformans Melanization, Antifungal Resistance, and Pathogenesis in a Murine Model of Drug Administration and Systemic Infection

Infect Immun 2022 Apr 21;90(4):e0009122. doi: 10.1128/iai.00091-22.

CRISPR and HIV: New Technique in Human Blood Unveils Potential Paths Toward Cure 

Feinberg News Center - Northwestern University | April 12, 2022

HIV cure research: Trying to eliminate a virus that 'hides out'

Healio | April 12, 2022

HIV remissions involving stem cells forward 'path toward finding a cure'

WTOP | April 6, 2022

CRISPR Technique Identifies New Genes Affecting HIV Infection

Contagion Live | April 4, 2022

The hunt for an AIDS vaccine approaches 40 with hope and caution

AAMC | March 31, 2022

Moderna hits the gas as it begins dosing of 2nd HIV vaccine

Fierce Biotech | March 14, 2022

mRNA Technology Leads to Advances in HIV Vaccine Candidate

Drug Topics | March 2, 2022

Stem-cell treatment may have cured woman of HIV

Medical News Today | February 22, 2022

What's the impact of the new HIV variant on the HIV response?

UNAIDS | February 22, 2022

Prevalence and outcome of HIV infected children admitted in a tertiary hospital in Northern Tanzania 

BMC Pediatr. 2022 Feb 21;22(1):101. doi: 10.1186/s12887-022-03105-8.

First woman reported cured of HIV after stem cell transplant

Arab News | February 16, 2022

Deep dive into HIV's hidden DNA finds that some people could eventually drop their drugs

aidsmap | January 24, 2022

Understanding Where HIV Hides Offers Clues for a Cure

POZ Magazine | January 17, 2022

Neuropilin-1, a myeloid cell-specific protein, is an inhibitor of HIV-1 infectivity

PNAS | January 11, 2022

Experimental mRNA HIV vaccine shows promise in animals

National Institutes of Health (NIH) | January 11, 2022

Assessment of Oral Health and Prevalence of oral Conditions in Human Immunodeficiency Virus-infected Subjects Visiting Antiretroviral Therapy Centers 

J Pharm Bioallied Sci. (Suppl 2):S1470-S1473. doi: 10.4103/jpbs.jpbs_256_21.

Institute Releases Strategic Plan, New Vision, Mission

NIH | January 2022

HIV patients 'cured' by their own unique biology may harbor secrets to end the global scourge 

Medical Xpress | December 31, 2021

mRNA Vaccine for HIV Looks Promising

Infectious Disease Special Edition | December 9, 2021

Q&A With Capt. Renee Joskow, NIDCR’s New Senior Advisor

NIH | December 2021

What can 35-year-old stool samples tell scientists about HIV/AIDS?

ScienceDaily | December 8, 2021

Novel technique solves structure of the HIV capsid alone and in complex with host factors 

News Medical | November 21, 2021

Patient's immune system 'naturally' cures HIV in the second case of its kind | Live Science 

Live Science | November 20, 2021

Webster-Cyriaque Selected as Deputy Director of NIDCR

UNC Health Care | November 19, 2021

HIV breakthrough offers hope as new vaccine crushes virus in stunning trial results

Daily Express November 12, 2021

Pidotimod and Immunological Activation in Individuals Infected with HIV 

Curr HIV Res. 2021;19(3):260-268. doi: 10.2174/1570162X18666210111102046.

New, highly innovative NIH research awards to address health disparities and advance health equity

NIH | October 13, 2021

Targeting Tat-TAR RNA Interaction for HIV-1 Inhibition 

Viruses. 2021 Oct 6;13(10):2004. doi: 10.3390/v13102004.

Researchers use exosome-based strategy to block HIV in mice

Science Daily | September 21, 2021

NIAID Scientists Find a Key to Hepatitis C Entry into Cells

NIH | September 21, 2021

Researchers advance the use of nanoparticles to deliver HIV/AIDS drugs to the brain

FIU News | September 17, 2021

Temple researchers take another step toward curing HIV

The Philadelphia Inquirer | September 17, 2021

A cure for HIV: Emory receives $23.8 million NIH grant to accelerate research - Emory News Center 

Emory News Center | September 9, 2021

To Stop HIV, Researchers Are Investigating an mRNA Vaccine

Healthline | September 5, 2021

Internet-Based HIV Self-Testing Among Men Who Have Sex With Men Through Pre-exposure Prophylaxis: 3-Month Prospective Cohort Analysis From China

NIH | August 27, 2021

HIV Cure Center at UNC to receive $26M in funding over 5 years

WRAL Tech Wire | August 20, 2021

Can These Three Gene Therapies Get Us Closer to an HIV Cure? 

POZ | August 13, 2021

A Randomized, Open Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study) 

AIDS Res Hum Retroviruses. 2021 Aug 12. doi: 10.1089/AID.2021.0096.

New Nanoparticle Drug Delivery System for HIV/AIDS Treatment 

AZoNano | August 12, 2021

Inflammasome Therapeutics to Develop Dual Sustained-Release HIV Prevention and Birth Control Implant

Business Wire | August 9, 2021

Response to Antiretroviral Therapy

Dove Press | 24 July 2021

Potential role of micro ribonucleic acids in screening for anal cancer in human papilloma virus and human immunodeficiency virus related malignancies

World J Gastrointest Pathophysiol. 2021 Jul 22;12(4):59-83. doi: 10.4291/wjgp.v12.i4.59

  2019 Archives 2020 Archives 2021 Archives